Comparison of Different Modes of Administration Tranexamic Acid in Reducing Post Operative Blood loss After Total Hip Replacement

Comparison of Different Modes of Administration Tranexamic Acid in Reducing Post Operative Blood loss After Total Hip Replacement:A Randomized Control Trial - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084566

Enrollment

102

Registered

2025-04-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M169- Osteoarthritis of hip, unspecified

Interventions

Intervention1: TRANEXAMIC ACID: Pateints undergoing total hip arthroplasty Preoperative Hemoglobin and Hematocrit levels will be measured using Wintrobe hematocrit tube on a Hematocrit centrifuged

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either gender Age more than 18 years Non Traumatic/elective cases of Primary Osteoarthritis ,Secondary Osteoarthritis of hip due to Septic Arthritis,Tuberculosis and Avasular necrosis Post Traumatic Arthritis Patient willing for participation in this study Hemoglobin level more than equal to 10gm/dl Packed Cell volume more than33%

Exclusion criteria

Exclusion criteria: Patients of either gender Age more than 18 years Non Traumatic/elective cases of Primary Osteoarthritis ,Secondary Osteoarthritis of hip due to Septic Arthritis,Tuberculosis and Avasular necrosis Post Traumatic Arthritis Patient willing for participation in this study Hemoglobin level more than equal to 10gm/dl Packed Cell volume more than33%

Design outcomes

Primary

Measure	Time frame
TO COMPARE THE EFFICACY OF DIFFERENT MODES OF TRANEXEMIC ACID IN REDUCING POST OPERATIVE BLOOD LOSS AFTER TOTAL HIP REPLACEMENT SURGERYTimepoint: 1-5th day	—

Secondary

Measure	Time frame
through this study we are also assessing the safety of tranexamic acidTimepoint: 0-5 days of administration	—

Countries

India

Contacts

Public ContactDr Amit Saraf

TEERTHANKAR MAHAVEER MEDICAL COLLEGE AND RESEARCH CENTRE

amitsaraf_75@yahoo.com09780029750

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026